Gliomatose leptomeningea primária difusa by Gonçalves, André Leite et al.
Arq Neuropsiquiatr 2008;66(1):85-87
 85
PRIMARY DIFFUSE LEPTOMENINGEAL GLIOMATOSIS
André Leite Gonçalves1, Marcelo Rodrigues Masruha1, Henrique Carrete Jr2,  
João Norberto Stávale3, Nasjla Saba da Silva4, Luiz Celso Pereira Vilanova1
GLIOMATOSE LEPTOMENINGEA PRIMÁRIA DIFUSA
Universidade Federal de São Paulo (UNIFESP), São Paulo SP, Brazil:  1Department of Neurology and Neurosurgery; 2Department of Radiology; 3Depart-
ment of Pathology; 4Department of Paediatrics / Paediatric Oncology Institute.
Received 12 June 2007, received in final form 23 October 2007. Accepted 24 November 2007.
Dr. André Leite Gonçalves – Division of Child Neurology / Departamento de Neurologia e Neurocirurgia - Rua Botucatu 720 – 04023-900 São Paulo 
SP - Brasil. E-mail: goncalvesnp@yahoo.com.br
Glioma arising primarily from the leptomeninges is ex-
tremely rare and often diagnosed only in postmortem ex-
amination. It is thought to derive from heterotopic nests 
of neuroglial tissue within the leptomeninges, which are 
present in 1% of necropsies. Primary leptomeningeal glio-
ma can be in the form of a solitary tumour or a diffuse tu-
mour involving intracranial or spinal cord leptomeninges1. 
We report a case of primary diffuse leptomeningeal 
gliomatosis (PDLG) established by meningeal biopsy. 
CASE
A 13-year-old boy initiated symptoms at age of 7 years, with 
a partial complex seizure. He remained stable until the age of 
8, when he presented another seizure. At this time he was ad-
mitted in coma into the critical care unit, and underwent treat-
ment for viral encephalitis with acyclovir for 14 days. He was 
discharged with clinical improvement. Afterwards he present-
ed recurrent headaches.
Two years later he was admitted with headache, neck stiff-
ness, drowsiness and vomiting. At this time an intracranial hy-
pertension syndrome was identified. The cranial MRI showed a 
communicating hypertensive hydrocephalus that required a ven-
triculoperitoneal shunt. He was stable up to the age of 11, when a 
dysfunction of the ventriculoperitoneal shunt was identified and 
the shunt was changed. At this time etiologic investigation for 
chronic meningitis was initiated. Histoplasma capsulatum was 
considered the probable agent, because of his positive epide-
miology and he underwent treatment with fluconazole. He was 
treated for two years and referred to our service.
On admission at our hospital, at age of 13, he complained of 
sporadic headache, which was being treated with sodium valpro-
ate and fluconazole, with no seizures in the last year. During the 
investigation, different lumbar punctures were performed with 
elevated protein levels (up to 5.4 g/L), but glucose levels were 
normal. CSF white blood cells were up to 80/mm³. No neoplas-
tic cells were detected. Acid fast bacilli smear, culture and tu-
berculosis DNA polymerase chain reaction (PCR) technique were 
all negative. Mycological analysis for histoplasmosis, paracoc-
cidioidomycosis, aspergillosis and candidiasis were all negative. 
Immunological reactions to syphilis, toxoplasmosis, cytomega-
lovirus, cysticercosis and brucellosis were negative. Electroen-
cephalograms revealed a generalized asynchronous slowing of 
background waves.
Cranial CT showed diffuse calcifications in the basal cisterns 
suggesting some consequence of inflammatory process (Fig 1A). 
Fig 1. (A) Axial CT demonstrates calcification along the surfaces of frontal and temporal lobes, suprasellar region and cerebellar 
vermis. Postgadolinium axial (B) and coronal (C) T1-weighted MR images. Note extensive enhancement of basal cisterns extend-
ing into lateral fissures after contrast (B and C). In C, note thickening of the left lateral ventricle ependyma. Sagital T1-weight-
ed postcontrast (D) MR images of lumbar spine demonstrate markedly leptomeningeal enhancement. 
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Non-enhanced cranial and spinal cord MRI was normal. Postg-
adolinium images revealed diffuse enhancement in cerebral sul-
ci, cerebellar vermis, basal, pontine and ambient cisterns (Fig 1B 
and 1C) and in the spinal cord (Fig 1D) with no evidence of intra-
parenchymal involvement. 
A meningeal biopsy was performed and histologic examina-
tion revealed an astrocytic glial proliferation in the subarach-
noid space (Fig 2A) with a positive stain for glial fibrillary acid-
ic protein (Fig 2B), conclusive for a low-grade glioma. Based on 
this result, associated with clinical and radiological data, a di-
agnosis of primary leptomeningeal gliomatosis, low grade glio-
ma type was made.
During this period, he was assessed by the oncology team 
and initiated temozolomide cycles, completing 22 cycles asso-
ciated to neuroaxis radiotherapy. He progressed with scarce sei-
zures, using valproate (Depakote) and acetazolamide (Diamox) 
and presented longitudinal nasal hemianopsy that evolved to 
complete involvement of the visual field. After the temozolo-
mide cycles, initiated chemotherapy sessions with ciisplatin and 
etoposide. At 16 years of age, he did not resist to a pulmonary 
infection and died after a cardiac and –respiratory arrest.
DISCUSSION
PDLG is a rare disease. It is characterized by a glioma, 
usually an astrocytoma, which arises in the leptomeninges 
of the brain or spinal cord with no involvement of intrapa-
renchymatous tissue2. Two anatomical and clinical forms 
have been described: a nodular form and a diffuse form3,4, 
which corresponds to our observation.
Debono et al.3 recently reviewed the literature on this 
subject and found only 30 cases previously reported. The 
mean age of clinical onset was 35 years, ranging from 9 
to 71 years, with no sex predominance. The neurological 
symptoms are mainly related to intracranial hypertension 
(83.8% of cases), followed by multiple cranial nerve palsy 
(35.5%) and epilepsy (29.03%). Other signs include hemi-
paresis and tetraparesis, behavioural changes, confusion, 
visual loss and gait disturbances, back pain, meningeal 
signs and coma.
CSF findings usually show an increase in protein levels 
with low or moderate pleocytosis3. Repeated CSF exami-
nations are usually negative for malignant cells; moreover, 
distinguishing chronic aseptic meningitis from leptomen-
ingeal carcinomatosis or gliomatosis may be difficult since 
malignant cells can be misinterpreted as benign macro-
phages. In assessing patient’s risk, immunocytochemistry 
with appropriate immunostains for GFAP or cytokeratins 
and epithelial membrane antigen (EMA) may be helpful4-7. 
However immunocytochemistry is not used in routine cy-
tological evaluation but frequently performed in the CSF 
after a positive brain biopsy.
Neuroradiological findings include ventriculomegaly 
with diffuse or focal leptomeningeal contrast enhance-
ment. The spinal cord is predominantly involved, either 
associated or not with contrast enhancement of the basal 
cisterns, cerebellum, brainstem and convexity3. A pattern 
of non-enhancing nodular lesions on the leptomeninges 
was described. In our patient these findings are similar 
to those reported in the literature with diffuse enhance-
ment in cerebral sulci, cerebellar vermis, basal, pontine 
and ambiens cisterns and in the entire spinal cord with no 
evidence of intraparenchymal involvement1,3.
Surgical meningeal biopsy is necessary in cases of 
chronic aseptic meningitis with areas of contrast enhance-
ment to determine the primary cause of this disease. In this 
case, meningeal biopsy was decisive to determine the eti-
ology of the disease and to establish the proper treatment. 
Differential diagnoses include carcinomatous men-
ingitis and autoimmune and inflammatory processes af-
fecting the meninges, such as tuberculous meningitis3,8-10. 
Treatment is intended to reduce the intracranial pressure. 
Some patients undergo a CSF diversion procedure in the 
form of ventriculoperitoneal or another alternative route 
shunting3.
Craniospinal radiation therapy and chemotherapy can 
be employed. Beauchesne et al.9 obtained a complete 
clinical and radiological remission for 15 months after a 
Fig 2. (A) HE, Meningeal biopsy show-
ing astrocytic glial proliferation in the 
sub-arachnoid space with a; (B) GFAP, 
positive stain for glial fibrillary acid-
ic protein, conclusive for a low-grade 
glioma.
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course of corticospinal tract radiation therapy and che-
motherapy. In our patient, remission occurred after com-
plete treatment, that is, thirty months later.
The prognosis is generally poor and survival depends 
on tumour grade and patients do not survive as long as 
ours. In this case, the long evolution, for nine years, is 
probably due to the fact it is a low-grade glioma. 
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